S0509 - AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
This phase II trial is study how well AZD2171 works in treating patients with malignant
pleural mesothelioma that cannot be removed by surgery. AZD2171 may stop the growth of tumor
cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to
the tumor